4th Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

implementation of Food and Drug Administration Safety and Innovation Act (PL 112-144); drug safety issues; prescription drug abuse; Senate HELP Committee's Innovation Working Group;

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

H.R. 9, Innovation Act; S. 1137, PATENT Act; S. 779, Fair Access to Science & Technology Research Act of 2015

LobbyistCovered position, as disclosed
TRACY SPICER —
AMY TEJRAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9 (114th), S. 1137 (114th), S. 779 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.